XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues        
Total revenues $ 354,264 $ 290,084 $ 944,844 $ 717,316
Operating expenses        
Cost of sales 55,242 49,426 150,004 117,362
Amortization of intangibles 17,762 17,762 53,286 53,287
Research and development 17,251 18,458 49,593 58,607
Selling, general and administrative 46,088 41,241 130,064 112,086
Total operating expenses 136,343 126,887 382,947 341,342
Operating income 217,921 163,197 561,897 375,974
Other income (expense)        
Investment and other income, net 5,333 6,474 19,042 16,499
Interest expense (4,296) (4,524) (13,215) (13,555)
Income before income tax expense 218,958 165,147 567,724 378,918
Income tax expense 43,733 28,136 109,244 71,839
Net income $ 175,225 $ 137,011 $ 458,480 $ 307,079
Earnings per share        
Basic (usd per share) $ 1.49 $ 1.08 $ 3.80 $ 2.42
Diluted (usd per share) $ 1.43 $ 1.05 $ 3.68 $ 2.37
Weighted average common shares outstanding        
Basic (in shares) 117,219 126,850 120,570 126,969
Diluted (in shares) 122,331 130,134 124,449 129,526
Royalties        
Revenues        
Total revenues $ 236,038 $ 155,061 $ 609,869 $ 400,572
Product sales, net        
Revenues        
Total revenues 94,228 86,659 253,779 224,128
Revenues under collaborative agreements        
Revenues        
Total revenues $ 23,998 $ 48,364 $ 81,196 $ 92,616